Omega Fund Management, LLC 13F Holdings
CIK 0001637359 · Boston, MA
As of Sep 30, 2025, Omega Fund Management, LLC reported 12 positions worth $222.4M in its SEC Form 13F filing.
Top 12 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES LTD | KMTS | Healthcare | 1,645,893 | $39.1M | 17.59% |
| BETA BIONICS INC | BBNX | Healthcare | 1,920,125 | $38.2M | 17.16% |
| BRIDGEBIO ONCOLOGY THERAPEUTICS ORD | BBOT | Healthcare | 3,289,661 | $38.1M | 17.13% |
| BICARA THERAPEUTICS INC | BCAX | Healthcare | 2,204,650 | $34.8M | 15.66% |
| NUVATION BIO INC | NUVB | Healthcare | 8,831,089 | $32.7M | 14.69% |
| UPSTREAM BIO INC | UPB | Healthcare | 1,356,293 | $25.5M | 11.47% |
| IMAGENEBIO INC | IMA | Healthcare | 455,361 | $3.7M | 1.67% |
| ENGENE HOLDINGS INC | ENGN | Healthcare | 526,357 | $3.6M | 1.62% |
| SANA BIOTECHNOLOGY INC | SANA | Healthcare | 843,750 | $3.0M | 1.35% |
| ALUMIS INC | ALMS | Healthcare | 653,223 | $2.6M | 1.17% |
| REPLIMUNE GROUP INC | REPL | Healthcare | 248,672 |